0001968582-24-000274.txt : 20240401
0001968582-24-000274.hdr.sgml : 20240401
20240401161732
ACCESSION NUMBER: 0001968582-24-000274
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240401
DATE AS OF CHANGE: 20240401
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Akero Therapeutics, Inc.
CENTRAL INDEX KEY: 0001744659
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-38944
FILM NUMBER: 24809526
BUSINESS ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD, SUITE 350
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-487-6488
MAIL ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD, SUITE 350
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Young Jonathan
CENTRAL INDEX KEY: 0001779805
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O AKERO THERAPEUTICS, INC.
STREET 2: 170 HARBOR WAY 3RD FL
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
144
1
primary_doc.xml
144
0001779805
XXXXXXXX
LIVE
0001744659
Akero Therapeutics, Inc.
001-38944
601 Gateway Boulevard
Suite 350
South San Francisco
CA
94080
650-487-6488
Jonathan Young
Officer
Common Stock
J.P. Morgan Securities LLC
390 Madison Avenue
6th Floor
New York
NY
10017
15000
379200
56297528
04/01/2024
NASDAQ
Common Stock
01/13/2020
Stock Option Exercise
Issuer
N
15000
01/13/2020
Cash
Y
04/01/2024
/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Jonathan Young